Levitra Is Big News On Wall Street, But Rx Firms Ask Investors To Think Small
Executive Summary
GlaxoSmithKline's levitating act in the third quarter shows that co-promotion deals have kept their magic for the company
You may also be interested in...
Merck Won’t Go Hollywood: In-House R&D Still Focus As Outside Deals Expand
Merck is on a pace to sign 50 outside R&D alliances during 2003
Merck Won’t Go Hollywood: In-House R&D Still Focus As Outside Deals Expand
Merck is on a pace to sign 50 outside R&D alliances during 2003
Wellbutrin SR Patent Needs Further Review, Appeals Court Agrees With GSK
An appeals court ruling for GlaxoSmithKline in Wellbutrin SR patent litigation against Andrx finds the district court erred in its construction of GSK's patent claims